Kryptos Biotechnologies, Inc.
PrivateLast Round
Grant
Mar 13, 2025
Est. Valuation
$48.5M
Total Funding Raised
$19.6M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Kryptos Biotechnologies, Inc. operates in Healthcare & Life Sciences and is based in Hayward, California. Its latest recorded funding round was a Grant round in March 2025.
Kryptos Biotechnologies, Inc. is a biotechnology company that develops point-of-care molecular diagnostic systems using ultrafast photonic PCR technology.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Biotechnology, Biotech Equipment
Business Model
B2B
Customer Profile
Hardware + Subscription, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Kryptos Biotechnologies, Inc. Comparables
Compare Kryptos Biotechnologies, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Rover Diagnostics | 90% | |
| Anavasi Diagnostics | 86% | |
| Alveo Technologies | 84% |
For institutional investors. Book with your work email.
Kryptos Biotechnologies, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Mar 13, 2025 | ||||
| Series A Extension | Feb 20, 2025 | ||||
| Grant | Jan 15, 2025 | ||||
| Series A | Apr 4, 2024 | ||||
| Pre-Series A | Nov 1, 2019 | ||||
Seed | Oct 1, 2019 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Kryptos Biotechnologies, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| KDB Capital Corp | Pre-Series A |
| Bridge Alliance Partners | Seed |
| FuturePlay | Pre-Series A |
| Coolidge Corner Investment | Pre-Series A |
| RIGHT Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 266% MoM.
- Feb 20, 2025
$2M round led by OSANG Healthcare Co., Ltd.
For institutional investors. Book with your work email.
Kryptos Biotechnologies, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Kryptos Biotechnologies, Inc.'s valuation, stock price, and market status.
Is Kryptos Biotechnologies, Inc. a public or private company?
Kryptos Biotechnologies, Inc. is a private company.
What is the current stock price of Kryptos Biotechnologies, Inc.?
Kryptos Biotechnologies, Inc. is a private company, so its shares have no public market price. Caplight tracks Kryptos Biotechnologies, Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Kryptos Biotechnologies, Inc. worth (valuation)?
Kryptos Biotechnologies, Inc.'s valuation is estimated at $48.5M based on funding round data.
Can I buy Kryptos Biotechnologies, Inc. stock?
Kryptos Biotechnologies, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Kryptos Biotechnologies, Inc.'s last funding round?
Kryptos Biotechnologies, Inc.'s most recent funding round was Grant on March 13, 2025.
Who are the main investors in Kryptos Biotechnologies, Inc.?
Key investors in Kryptos Biotechnologies, Inc. include FuturePlay.
Will Kryptos Biotechnologies, Inc. IPO soon?
No public IPO plans have been announced for Kryptos Biotechnologies, Inc..
How can I track Kryptos Biotechnologies, Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Kryptos Biotechnologies, Inc.'s shares on secondary markets.